Richard Malamut
Chief Tech/Sci/R&D Officer at MEDINCELL S.A.
Net worth: - $ as of 2024-03-30
Profile
Richard Malamut is currently the Director at Chromocell Therapeutics Corp.
and the Chief Medical Officer at MedinCell SA. Previously, he held positions as the Vice President-Global Clinical Development at Teva Pharmaceutical Industries Ltd.
from 2013 to 2016, the Chief Medical Officer at Avanir Pharmaceuticals, Inc., the Chief Medical Officer & Executive Vice President at Collegium Pharmaceutical, Inc. from 2019 to 2022, and the Chief Medical Officer & Senior Vice President at Braeburn, Inc. from 2018 to 2019.
He obtained his doctorate degree from Hahnemann University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-15 | 0 ( -.--% ) | - $ | 2024-03-30 |
Richard Malamut active positions
| Companies | Position | Start |
|---|---|---|
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | 2022-05-08 |
| CHROMOCELL THERAPEUTICS CORPORATION | Director/Board Member | 2022-12-31 |
Former positions of Richard Malamut
| Companies | Position | End |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Chief Tech/Sci/R&D Officer | 2022-03-22 |
| BRAEBURN INC. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2016-10-31 |
| AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Training of Richard Malamut
| Hahnemann University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Private companies | 3 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
| Chromocell Therapeutics Corp. |
- Stock Market
- Insiders
- Richard Malamut
